Corporate VCs Do More than Their Fair Share of Private Biotech Financing
This article was originally published in Start Up
Executive Summary
Although venture capitalists have cut back the amount of money they invested in private biotechs during the 2001-2003 timeframe, corporate VCs bucked the trend and continued to participate consistently in supporting these firms with equity investments.